Stockreport

Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress

Psyence Biomedical Ltd. - Ordinary Shares  (PBM) 
PDF Independent valuation of PsyLabs values Psyence Biomed’s stake at approximately $2 million, doubling in value Debt-for-equity swap with Psyence Group and Newcourt SPAC [Read more]